所有产品
  • 抗体
  • 试剂盒
  • 多肽
  • 探针
  • 蛋白
  • 生化试剂
  • 组织芯片
EN
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
乳腺
当前位置：首页 > 组织芯片 > 乳腺 > 乳腺
组织芯片
乳腺癌，75例，150芯（1.1mm），系列3
  • 货号： BRC1503
  • 芯片名称： 乳腺癌，75例，150芯（1.1mm），系列3
  • 芯片描述： 乳腺癌组织芯片，系列3，不与BRC1501，BRC1502，BRC1504 到BRC15011重复，150芯，包括正常/良性（5例）和癌（70例）组织提供分级，TNM分期，和AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。
定制服务咨询
详细相关信息
武汉天德生物病理生物芯片系列-BRC1503
芯片编号 BRC1503
芯片名称 乳腺癌，75例，150芯（1.1mm），系列3
芯片说明 乳腺癌组织芯片，系列3，不与BRC1501，BRC1502，BRC1504 到BRC15011重复，150芯，包括正常/良性（5例）和癌（70例）组织提供分级，TNM分期，和AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。
点数: 150芯
例数: 75例
组织固定方式: 福尔马林固定24h
QA/QC: HE染色和IHC染色
应用: 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH)，可以在我们的技术支持页面找到操作流程。
注意事项: 1.收到产品后请常温保存，并在24个月内使用，2.请在实验前60°烤片30分钟，3.请选择温和的修复方式，以免造成组织脱落。
                         
Array Name Array position Order Sex Age Anatomic site Pathology  Nature Grade Stage (TNM) Intensity Percentage Comment
BRC1503 A01 1 F 26 Breast Normal Normal 　 　 0 　 　
BRC1503 A02 2 F 45 Breast Adenosis Benign 　 　 0 　 　
BRC1503 A03 3 F 35 Breast Adenosis Benign 　 　 0 　 　
BRC1503 A04 4 F 23 Breast Fibroadenoma Benign 　 　 0 　 　
BRC1503 A05 5 F 40 Breast Fibrocystic disease Benign 　 　 0 　 　
BRC1503 A06 6 F 45 Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1503 A07 7 F 42 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 A08 8 F 32 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1503 A09 9 F 48 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 A10 10 F 44 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 1 8% 　
BRC1503 A11 11 F 50 Breast Invasive ductal carcinoma Malignant III T2N0M0 1 8% 　
BRC1503 A12 12 F 63 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 A13 13 F 42 Breast Invasive lobular carcinoma Malignant II~III T2N0M0 1 8% 　
BRC1503 A14 14 F 46 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 A15 15 F 34 Breast Invasive lobular carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 B01 16 F 26 Breast Normal Normal 　 　 0 　 　
BRC1503 B02 17 F 45 Breast Adenosis Benign 　 　 0 　 　
BRC1503 B03 18 F 35 Breast Adenosis Benign 　 　 0 　 　
BRC1503 B04 19 F 23 Breast Fibroadenoma Benign 　 　 0 　 　
BRC1503 B05 20 F 40 Breast Fibrocystic disease Benign 　 　 0 　 　
BRC1503 B06 21 F 45 Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1503 B07 22 F 42 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 B08 23 F 32 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1503 B09 24 F 48 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 B10 25 F 44 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 1 8% 　
BRC1503 B11 26 F 50 Breast Invasive ductal carcinoma Malignant III T2N0M0 1 8% 　
BRC1503 B12 27 F 63 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 B13 28 F 42 Breast Invasive lobular carcinoma Malignant II~III T2N0M0 1 8% 　
BRC1503 B14 29 F 46 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 B15 30 F 34 Breast Invasive lobular carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 C01 31 F 53 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 C02 32 F 25 Breast Lobular carcinoma in situ Malignant 　 TisN0M0 2 15% 　
BRC1503 C03 33 F 45 Breast Invasive lobular carcinoma Malignant II~III T2N0M0 0.5 　 　
BRC1503 C04 34 F 44 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 C05 35 F 38 Breast Invasive ductal carcinoma Malignant I~II T2N0M0 0 　 　
BRC1503 C06 36 F 70 Breast Invasive ductal carcinoma Malignant II T2N0M0 2 30% 　
BRC1503 C07 37 F 56 Breast Invasive ductal carcinoma Malignant II~III T3N1M0 0 　 　
BRC1503 C08 38 F 52 Breast Invasive ductal carcinoma Malignant 　 TisN0M0 0 　 　
BRC1503 C09 39 F 68 Breast Invasive ductal carcinoma Malignant II~III T1N0M0 2 20% 　
BRC1503 C10 40 F 68 Breast Invasive ductal carcinoma Malignant II~III T3N1M0 1 5% 　
BRC1503 C11 41 F 46 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 C12 42 F 52 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 C13 43 F 59 Breast Invasive ductal carcinoma Malignant II~III T3N1M0 0 　 　
BRC1503 C14 44 F 39 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 1 5% 　
BRC1503 C15 45 F 40 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 D01 46 F 53 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 D02 47 F 25 Breast Lobular carcinoma in situ Malignant 　 TisN0M0 2 15% 　
BRC1503 D03 48 F 45 Breast Invasive lobular carcinoma Malignant II~III T2N0M0 0.5 　 　
BRC1503 D04 49 F 44 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 D05 50 F 38 Breast Invasive ductal carcinoma Malignant I~II T2N0M0 0 　 　
BRC1503 D06 51 F 70 Breast Invasive ductal carcinoma Malignant II T2N0M0 2 30% 　
BRC1503 D07 52 F 56 Breast Invasive ductal carcinoma Malignant II~III T3N1M0 0 　 　
BRC1503 D08 53 F 52 Breast Invasive ductal carcinoma Malignant 　 TisN0M0 0 　 　
BRC1503 D09 54 M 68 Breast Invasive ductal carcinoma Malignant II~III T1N0M0 2 20% 　
BRC1503 D10 55 F 68 Breast Invasive ductal carcinoma Malignant II~III T3N1M0 1 5% 　
BRC1503 D11 56 F 46 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 D12 57 F 52 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 D13 58 F 59 Breast Invasive ductal carcinoma Malignant II~III T3N1M0 0 　 　
BRC1503 D14 59 F 39 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 1 5% 　
BRC1503 D15 60 F 40 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 E01 61 F 40 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 1 5% 　
BRC1503 E02 62 F 60 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 E03 63 F 50 Breast Invasive ductal carcinoma Malignant II~III T1N0M0 1 8% 　
BRC1503 E04 64 F 45 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2 20% 　
BRC1503 E05 65 F 46 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 E06 66 F 39 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 2 20% 　
BRC1503 E07 67 F 48 Breast Invasive ductal carcinoma Malignant II~III T1N0M0 1 8% 　
BRC1503 E08 68 F 41 Breast Invasive ductal carcinoma Malignant II T2N0M0 2 25% 　
BRC1503 E09 69 F 61 Breast Lobular carcinoma in situ Malignant 　 TisN0M0 1 8% 　
BRC1503 E10 70 F 86 Breast Invasive carcinoma with apocrine features Malignant III T2N0M0 1 5% 　
BRC1503 E11 71 F 34 Breast Invasive ductal carcinoma Malignant II~III T3N3M0 0 　 　
BRC1503 E12 72 F 64 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 E13 73 F 35 Breast Invasive lobular carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 E14 74 F 44 Breast Invasive tubular carcinoma Malignant II T2N1M0 1 8% 　
BRC1503 E15 75 F 54 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 F01 76 F 40 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 1 5% 　
BRC1503 F02 77 F 60 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 F03 78 F 50 Breast Invasive ductal carcinoma Malignant II~III T1N0M0 1 8% 　
BRC1503 F04 79 F 45 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2 20% 　
BRC1503 F05 80 F 46 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 F06 81 F 39 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 2 20% 　
BRC1503 F07 82 F 48 Breast Invasive ductal carcinoma Malignant II~III T1N0M0 1 8% 　
BRC1503 F08 83 F 41 Breast Invasive ductal carcinoma Malignant II T2N0M0 2 25% 　
BRC1503 F09 84 F 61 Breast Lobular carcinoma in situ Malignant 　 TisN0M0 1 8% 　
BRC1503 F10 85 F 86 Breast Invasive carcinoma with apocrine features Malignant III T2N0M0 1 5% 　
BRC1503 F11 86 F 34 Breast Invasive ductal carcinoma Malignant II~III T3N3M0 0 　 　
BRC1503 F12 87 F 64 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 F13 88 F 35 Breast Invasive lobular carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 F14 89 F 44 Breast Invasive tubular carcinoma Malignant II T2N1M0 1 8% 　
BRC1503 F15 90 F 54 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 G01 91 F 40 Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1503 G02 92 F 58 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 G03 93 F 55 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 G04 94 F 74 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 G05 95 F 50 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 1 5% 　
BRC1503 G06 96 F 53 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 G07 97 F 53 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2 15% 　
BRC1503 G08 98 F 71 Breast Invasive ductal carcinoma Malignant II T4N0M0 1 8% 　
BRC1503 G09 99 F 48 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2.5 50% 　
BRC1503 G10 100 F 43 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 G11 101 F 34 Breast Intra-ductal carcinoma Malignant 　 TisN0M0 2 15% 　
BRC1503 G12 102 F 52 Breast Invasive ductal carcinoma Malignant II T2N0M0 2 15% 　
BRC1503 G13 103 F 55 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 G14 104 F 54 Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1503 G15 105 F 40 Breast Invasive ductal carcinoma Malignant II T2N1M0 1 5% 　
BRC1503 H01 106 F 40 Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1503 H02 107 F 58 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 H03 108 F 55 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 H04 109 F 74 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 H05 110 F 50 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 1 5% 　
BRC1503 H06 111 F 53 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 H07 112 F 53 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2 15% 　
BRC1503 H08 113 F 71 Breast Invasive ductal carcinoma Malignant II T4N0M0 1 8% 　
BRC1503 H09 114 F 48 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2.5 50% 　
BRC1503 H10 115 F 43 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 8% 　
BRC1503 H11 116 F 34 Breast Intra-ductal carcinoma Malignant 　 TisN0M0 2 15% 　
BRC1503 H12 117 F 52 Breast Invasive ductal carcinoma Malignant II T2N0M0 2 15% 　
BRC1503 H13 118 F 55 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 H14 119 F 54 Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1503 H15 120 F 40 Breast Invasive ductal carcinoma Malignant II T2N1M0 1 5% 　
BRC1503 I01 121 F 34 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 I02 122 F 59 Breast Invasive ductal carcinoma Malignant II~III T1N0M0 2 35% 　
BRC1503 I03 123 F 76 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1503 I04 124 F 39 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2 25% 　
BRC1503 I05 125 F 33 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 I06 126 F 52 Breast Invasive ductal carcinoma Malignant II T2N0M0 2 15% 　
BRC1503 I07 127 F 72 Breast Invasive ductal carcinoma Malignant II~III T4N0M0 1 8% 　
BRC1503 I08 128 F 35 Breast Invasive ductal carcinoma Malignant I~II T3N1M0 2 20% 　
BRC1503 I09 129 F 60 Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1503 I10 130 F 37 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2 20% 　
BRC1503 I11 131 F 53 Breast Invasive ductal carcinoma Malignant II~III T3N0M0 0 　 　
BRC1503 I12 132 F 52 Breast Invasive lobular carcinoma Malignant II~III T1N0M0 2.5 50% 　
BRC1503 I13 133 F 71 Breast Invasive ductal carcinoma Malignant II T2N0M0 3 60% 　
BRC1503 I14 134 F 70 Breast Tubular mixed carcinoma Malignant II~III T1N0M0 3 60% 　
BRC1503 I15 135 F 44 Breast Intra-ductal carcinoma Malignant 　 TisN0M0 0 　 　
BRC1503 J01 136 F 34 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 0 　 　
BRC1503 J02 137 F 59 Breast Invasive ductal carcinoma Malignant II~III T1N0M0 2 35% 　
BRC1503 J03 138 F 76 Breast Invasive ductal carcinoma Malignant II T2N0M0 1 5% 　
BRC1503 J04 139 F 39 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2 25% 　
BRC1503 J05 140 F 33 Breast Invasive ductal carcinoma Malignant II~III T2N1M0 0 　 　
BRC1503 J06 141 F 52 Breast Invasive ductal carcinoma Malignant II T2N0M0 2 15% 　
BRC1503 J07 142 F 72 Breast Invasive ductal carcinoma Malignant II~III T4N0M0 1 8% 　
BRC1503 J08 143 F 35 Breast Invasive ductal carcinoma Malignant I~II T3N1M0 2 20% 　
BRC1503 J09 144 F 60 Breast Invasive ductal carcinoma Malignant II T2N0M0 0 　 　
BRC1503 J10 145 F 37 Breast Invasive ductal carcinoma Malignant II~III T2N0M0 2 20% 　
BRC1503 J11 146 F 53 Breast Invasive ductal carcinoma Malignant II~III T3N0M0 0 　 　
BRC1503 J12 147 F 52 Breast Invasive lobular carcinoma Malignant II~III T1N0M0 2.5 50% 　
BRC1503 J13 148 F 71 Breast Invasive ductal carcinoma Malignant II T2N0M0 3 60% 　
BRC1503 J14 149 F 70 Breast Tubular mixed carcinoma Malignant II~III T1N0M0 3 60% 　
BRC1503 J15 150 F 44 Breast Intra-ductal carcinoma Malignant 　 TisN0M0 0